CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,078 | $432.59 | $899K | 39,232 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,652 | $433.45 | $716K | 37,580 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −798 | $434.76 | $347K | 36,782 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1 | $435.42 | $435 | 36,781 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 33,000 | ||
| 2025-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $430.23 | $645K | 2,630 |
| 2025-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,654 | $431.51 | $714K | 976 |
| 2025-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −846 | $432.86 | $366K | 130 |
| 2025-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 178,000 | ||
| 2025-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $433.42 | $433K | 3,130 |
| 2025-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $434.80 | $435K | 2,130 |
| 2025-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $436.47 | $873K | 130 |
| 2025-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 182,000 | ||
| 2025-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −522 | $432.74 | $226K | 3,608 |
| 2025-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,478 | $434.01 | $641K | 2,130 |
| 2025-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $441.26 | $883K | 130 |
| 2025-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 186,000 |
Page 192 of 214 · 4,273 trades